Transcription factor Nrf2 induces the up-regulation of lncRNA TUG1 to promote progression and adriamycin resistance in urothelial carcinoma of the bladder

Zhulei Sun,1 Gui Huang,1 Hepeng Cheng21Department of Pathology, Huaihe Hospital of Henan University, Kaifeng, People’s Republic of China; 2Department of Urology, Huaihe Hospital of Henan University, Kaifeng, People’s Republic of ChinaBackground: Taurine-upregulated gene 1 (TUG1)...

Full description

Bibliographic Details
Main Authors: Sun Z, Huang G, Cheng H
Format: Article
Language:English
Published: Dove Medical Press 2019-07-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/transcription-factor-nrf2-induces-the-up-regulation-of-lncrna-tug1-to--peer-reviewed-article-CMAR
id doaj-0121385ffe384c268a368a796ebc12ec
record_format Article
spelling doaj-0121385ffe384c268a368a796ebc12ec2020-11-25T00:16:16ZengDove Medical PressCancer Management and Research1179-13222019-07-01Volume 116079609046847Transcription factor Nrf2 induces the up-regulation of lncRNA TUG1 to promote progression and adriamycin resistance in urothelial carcinoma of the bladderSun ZHuang GCheng HZhulei Sun,1 Gui Huang,1 Hepeng Cheng21Department of Pathology, Huaihe Hospital of Henan University, Kaifeng, People’s Republic of China; 2Department of Urology, Huaihe Hospital of Henan University, Kaifeng, People’s Republic of ChinaBackground: Taurine-upregulated gene 1 (TUG1) has been documented to be implicated in carcinogenesis and chemoresistance in solid tumors. Here, we explored the biological role and regulatory mechanism of TUG1 in progression and chemoresistance of urothelial carcinoma of the bladder (UCB).Methods: Nuclear factor-erythroid 2 (NF-E2)-related factor 2 (Nrf2) mRNA and TUG1 expression was determined by quantitative reverse transcription polymerase chain reaction. Western blot was performed to determine the protein levels of Nrf2, p-glycoprotein (p-gp), Ki-67 (Ki67), matrix metalloproteinase (MMP)-2 and MMP-9 and cleaved caspase-3. The effects of either Nrf2 or TUG1 knockdown on the proliferation, invasion, apoptosis and adriamycin (ADM) resistance of UCB cells were evaluated by CCK-8 assay, transwell invasion assay and flow cytometry analysis. Xenograft tumor assay was carried out to confirm the role of Nrf2 and TUG1 in ADM resistance of UCB cells in vivo.Results: Nrf2 and TUG1 were upregulated in UCB tissues and cell lines. A positive correlation between Nrf2 and TUG1 expression was discovered in UCB tissues. Moreover, Nrf2 and TUG1 expression levels were higher in ADM-resistant cells compared with those in parental cells. Furthermore, Nrf2 positively regulated the expression of TUG1 in UCB cells. Knockdown of either Nrf2 or TUG1 led to the inhibition of cell proliferation and invasion and promotion of cell apoptosis, accompanying with down-regulation of Ki67, MMP-2 and MMP-9 and up-regulation of cleaved caspase-3. Knockdown of either Nrf2 or TUG1 enhanced the sensitivity of BIU-87/ADM and T24/ADM cells to ADM, as indicated by decreased expression of p-gp. Besides, knockdown of either Nrf2 or TUG1 inhibited tumor growth in the absence or presence of ADM in vivo.Conclusions: Nrf2 induces the up-regulation of TUG1 to promote progression and ADM resistance in UCB.Keywords: urothelial carcinoma of the bladder, nuclear factor-erythroid 2 (NF-E2)-related factor 2, taurine-upregulated gene 1, adriamycinhttps://www.dovepress.com/transcription-factor-nrf2-induces-the-up-regulation-of-lncrna-tug1-to--peer-reviewed-article-CMARurothelial carcinoma of the bladdernuclear factor-erythroid 2 (NF-E2)-related factor 2taurine-upregulated gene 1adriamycin
collection DOAJ
language English
format Article
sources DOAJ
author Sun Z
Huang G
Cheng H
spellingShingle Sun Z
Huang G
Cheng H
Transcription factor Nrf2 induces the up-regulation of lncRNA TUG1 to promote progression and adriamycin resistance in urothelial carcinoma of the bladder
Cancer Management and Research
urothelial carcinoma of the bladder
nuclear factor-erythroid 2 (NF-E2)-related factor 2
taurine-upregulated gene 1
adriamycin
author_facet Sun Z
Huang G
Cheng H
author_sort Sun Z
title Transcription factor Nrf2 induces the up-regulation of lncRNA TUG1 to promote progression and adriamycin resistance in urothelial carcinoma of the bladder
title_short Transcription factor Nrf2 induces the up-regulation of lncRNA TUG1 to promote progression and adriamycin resistance in urothelial carcinoma of the bladder
title_full Transcription factor Nrf2 induces the up-regulation of lncRNA TUG1 to promote progression and adriamycin resistance in urothelial carcinoma of the bladder
title_fullStr Transcription factor Nrf2 induces the up-regulation of lncRNA TUG1 to promote progression and adriamycin resistance in urothelial carcinoma of the bladder
title_full_unstemmed Transcription factor Nrf2 induces the up-regulation of lncRNA TUG1 to promote progression and adriamycin resistance in urothelial carcinoma of the bladder
title_sort transcription factor nrf2 induces the up-regulation of lncrna tug1 to promote progression and adriamycin resistance in urothelial carcinoma of the bladder
publisher Dove Medical Press
series Cancer Management and Research
issn 1179-1322
publishDate 2019-07-01
description Zhulei Sun,1 Gui Huang,1 Hepeng Cheng21Department of Pathology, Huaihe Hospital of Henan University, Kaifeng, People’s Republic of China; 2Department of Urology, Huaihe Hospital of Henan University, Kaifeng, People’s Republic of ChinaBackground: Taurine-upregulated gene 1 (TUG1) has been documented to be implicated in carcinogenesis and chemoresistance in solid tumors. Here, we explored the biological role and regulatory mechanism of TUG1 in progression and chemoresistance of urothelial carcinoma of the bladder (UCB).Methods: Nuclear factor-erythroid 2 (NF-E2)-related factor 2 (Nrf2) mRNA and TUG1 expression was determined by quantitative reverse transcription polymerase chain reaction. Western blot was performed to determine the protein levels of Nrf2, p-glycoprotein (p-gp), Ki-67 (Ki67), matrix metalloproteinase (MMP)-2 and MMP-9 and cleaved caspase-3. The effects of either Nrf2 or TUG1 knockdown on the proliferation, invasion, apoptosis and adriamycin (ADM) resistance of UCB cells were evaluated by CCK-8 assay, transwell invasion assay and flow cytometry analysis. Xenograft tumor assay was carried out to confirm the role of Nrf2 and TUG1 in ADM resistance of UCB cells in vivo.Results: Nrf2 and TUG1 were upregulated in UCB tissues and cell lines. A positive correlation between Nrf2 and TUG1 expression was discovered in UCB tissues. Moreover, Nrf2 and TUG1 expression levels were higher in ADM-resistant cells compared with those in parental cells. Furthermore, Nrf2 positively regulated the expression of TUG1 in UCB cells. Knockdown of either Nrf2 or TUG1 led to the inhibition of cell proliferation and invasion and promotion of cell apoptosis, accompanying with down-regulation of Ki67, MMP-2 and MMP-9 and up-regulation of cleaved caspase-3. Knockdown of either Nrf2 or TUG1 enhanced the sensitivity of BIU-87/ADM and T24/ADM cells to ADM, as indicated by decreased expression of p-gp. Besides, knockdown of either Nrf2 or TUG1 inhibited tumor growth in the absence or presence of ADM in vivo.Conclusions: Nrf2 induces the up-regulation of TUG1 to promote progression and ADM resistance in UCB.Keywords: urothelial carcinoma of the bladder, nuclear factor-erythroid 2 (NF-E2)-related factor 2, taurine-upregulated gene 1, adriamycin
topic urothelial carcinoma of the bladder
nuclear factor-erythroid 2 (NF-E2)-related factor 2
taurine-upregulated gene 1
adriamycin
url https://www.dovepress.com/transcription-factor-nrf2-induces-the-up-regulation-of-lncrna-tug1-to--peer-reviewed-article-CMAR
work_keys_str_mv AT sunz transcriptionfactornrf2inducestheupregulationoflncrnatug1topromoteprogressionandadriamycinresistanceinurothelialcarcinomaofthebladder
AT huangg transcriptionfactornrf2inducestheupregulationoflncrnatug1topromoteprogressionandadriamycinresistanceinurothelialcarcinomaofthebladder
AT chengh transcriptionfactornrf2inducestheupregulationoflncrnatug1topromoteprogressionandadriamycinresistanceinurothelialcarcinomaofthebladder
_version_ 1725383583789481984